logo

Amicus Therapeutics Inc (FOLD) Stock: A Year of Stock Market Ups and Downs

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Amicus Therapeutics Inc’s current trading price is -18.74% away from its 52-week high, while its distance from the 52-week low is 22.06%. The stock’s price range during this period has varied between $9.70 and $14.57. The company, active in the Healthcare sector, saw a trading volume of around 3.7 million for the day, considerably higher average daily volume of 3.24 million observed over the last three months.

In terms of market performance, Amicus Therapeutics Inc had a somewhat regular. The highest value for the stock in the past year was $14.57 on 12/28/23, while the lowest value was $9.70 on 11/10/23.

How Financial Performance Impacts Market Capitalization

Amicus Therapeutics Inc (FOLD) has experienced a quarterly decline of -6.92% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.50B and boasts a workforce of 517 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 12.30, with a change in price of +0.81. Similarly, Amicus Therapeutics Inc recorded 3,162,931 in trading volume during the last 100 days, posting a change of +7.34%.

How FOLD’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for FOLD stands at 2.78. Similarly, the long-term debt-to-equity ratio is also 2.73.

FOLD Stock Stochastic Average

As of today, the raw stochastic average of Amicus Therapeutics Inc over the past 50 days is 17.43%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 17.89%. Additionally, the Stochastic %K and %D values for the company were 10.11% and 6.96%, respectively, over the past 20 days.

FOLD Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -16.56%.However, over the last six months, we can see a stronger performance of -8.07%. Over the last 30 days, the price of FOLD has leaped by -13.95%. And in the last five days, it has surged by 0.42%.